FIELD: medicine; ophthalmology; dermatology.
SUBSTANCE: group of inventions is intended for prevention and/or treatment of skin disease and eye disease associated with osmotic imbalance. Pharmaceutical and cosmetic compositions of lipoic acid and taurine for preventing and/or treating (a) skin diseases and/or (b) eye disease, associated with osmotic imbalance, are characterized by that the weight ratio of lipoic acid to taurine ranges from 0.004 to 0.05.
EFFECT: group of inventions enables providing more effective prevention and/or treatment of skin diseases and/or eye diseases associated with osmotic imbalance.
18 cl, 4 dwg, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITION CONTAINING LIPOIC ACID AND A MUCOMIMETIC POLYMER | 2016 |
|
RU2724955C2 |
| PRESERVATIVE-FREE TOPICAL COMPOSITION, INCLUDING HYALURONIC ACID | 2011 |
|
RU2635473C2 |
| NEW BIAROMATIC PROPINYL COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING THEM, AND THEIR APPLICATION | 2017 |
|
RU2753863C2 |
| COMPOSITIONS AND METHODS FOR TREATING VISUAL ORGAN DISORDERS | 2018 |
|
RU2761436C1 |
| OPHTHALMIC COMPOSITIONS AND METHODS OF TREATING EYES | 2005 |
|
RU2410081C2 |
| OPHTHALMOLOGIC GEL OF TAURINE | 2016 |
|
RU2623205C1 |
| PEGYLATED LIPID NANOPARTICLE WITH A BIOACTIVE LIPOPHILIC COMPOUND | 2016 |
|
RU2737893C2 |
| N-LIPOIC AMINO ACID OR PEPTIDE, DERIVATIVES AND USE THEREOF | 2016 |
|
RU2737377C2 |
| IMPROVED METHODS AND COMPOSITIONS FOR SAFE AND EFFECTIVE TREATMENT OF TELANGIECTASIA | 2011 |
|
RU2535008C2 |
| SELECTIVE INHIBITORY PEPTIDES Nox-1 AND USE THEREOF | 2014 |
|
RU2699726C2 |
